Showing results (141-150 of 318) with videos related to

Sort By:
Pageof 32
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 5, 2015
[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma]Zhihui Zhang, Xilan Wu, Jianming Ying, et al.
Thoracic Cancer|July 2, 2022
Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNAYan Li, Ziyi Xu, Shouzheng Wang, et al.
BMJ Open|February 14, 2020
Physician preferences for chemotherapy in the treatment of non-small cell lung cancer in China: evidence from multicentre discrete choice experimentsHui Sun, Huishan Wang, Lizheng Shi, et al.
Frontiers in Pharmacology|October 3, 2022
<i>EGFR</i> uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitorsHaiyan Xu, Guangjian Yang, Runze Liu, et al.
Journal of Experimental Botany|February 3, 2016
Xylan synthesized by Irregular Xylem 14 (IRX14) maintains the structure of seed coat mucilage in ArabidopsisRuibo Hu, Junling Li, Xiaoyu Wang, et al.
Frontiers in Oncology|May 16, 2020
Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung CancerYuxin Mu, Ke Yang, Xuezhi Hao, et al.
Translational Lung Cancer Research|February 9, 2026
Efficacy and safety of lorlatinib in first-line and subsequent-line treatments for patients with ALK-positive non-small cell lung cancer: a single-center real-world study in ChinaLige Wu, Jiayu Liu, Zihua Zou, et al.
Plos One|March 7, 2024
Rice-Magnaporthe oryzae interactions in resistant and susceptible rice cultivars under panicle blast infection based on defense-related enzyme activities and metabolomicsXiurong Yang, Shuangyong Yan, Guangsheng Li, et al.
Nuclear Medicine and Biology|December 31, 2013
Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancerJunling Li, Huaiyu Zheng, Paula J Bates, et al.
Cancer Management and Research|October 1, 2019
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinibHongge Liang, Di Ma, Yan Xu, et al.
Pageof 32